Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography
- PMID: 17728550
- DOI: 10.1159/000104758
Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography
Abstract
Purpose: To evaluate central serous chorioretinopathy (CSCR) by means of optical coherence tomography (OCT) and multifocal electroretinogram (mf-ERG) at presentation and after resolution of the acute phase.
Design: Prospective comparative observational case series with a normal sample.
Patients and method: Twenty-one eyes of 21 patients with unilateral CSCR were examined. Both eyes underwent complete ophthalmological examination, which included measurement of best-corrected visual acuity, fluorescein angiography, OCT and mf-ERG recording. Our results were compared with the corresponding findings of 33 normal volunteers of the same age.
Results: At presentation, the averaged mean retinal thickness of the fovea, measured by OCT, was 303 mum in the affected eyes, 69.3% higher compared to the normal controls (p < 0.001). The averaged mean retinal response density of the mf-ERG of the affected eyes in area 1 was 11.29 nV/degree(2), 50.8% lower compared to the normal controls (p < 0.001). After regression of CSCR, the averaged mean retinal thickness of the fovea was 213 microm in the affected eyes, 19.3% greater compared to the normal controls (p < 0.001). The averaged mean retinal response density of the mf-ERG of the affected eyes in area 1 was 16.05 nV/degree(2), 30.1% lower compared to normal controls (p < 0.001). It is interesting that 6 of 21 fellow nonaffected eyes showed abnormal values, with an averaged mean retinal thickness of OCT (246 mum) and an averaged mean retinal response density of mf-ERG in area 1 (12 microV/degree(2)). In the remaining 15 eyes, the OCT and the mf-ERG values were within normal limits.
(c) 2007 S. Karger AG, Basel.
Similar articles
-
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.Ophthalmology. 2008 Sep;115(9):1494-500, 1500.e1-2. doi: 10.1016/j.ophtha.2008.01.021. Epub 2008 Apr 18. Ophthalmology. 2008. PMID: 18394706
-
Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography.Ophthalmology. 2007 Dec;114(12):2197-207. doi: 10.1016/j.ophtha.2007.02.015. Epub 2007 May 15. Ophthalmology. 2007. PMID: 17507096
-
Elongation of photoreceptor outer segment in central serous chorioretinopathy.Am J Ophthalmol. 2008 Jan;145(1):162-168. doi: 10.1016/j.ajo.2007.08.024. Epub 2007 Oct 29. Am J Ophthalmol. 2008. PMID: 18028861
-
[Central serous choroidoretinopathy (CSCR)--the diagnostics, monitoring and treatment].Klin Oczna. 2008;110(10-12):397-400. Klin Oczna. 2008. PMID: 19195175 Review. Polish.
-
[Central serous chorioretinopathy in a pregnant woman].J Fr Ophtalmol. 1996;19(3):216-21. J Fr Ophtalmol. 1996. PMID: 8731772 Review. French.
Cited by
-
Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy.Life (Basel). 2023 May 16;13(5):1194. doi: 10.3390/life13051194. Life (Basel). 2023. PMID: 37240839 Free PMC article.
-
Wide-field OCT-angiography assessment of choroidal thickness and choriocapillaris in eyes with central serous chorioretinopathy.Front Physiol. 2022 Oct 21;13:1008038. doi: 10.3389/fphys.2022.1008038. eCollection 2022. Front Physiol. 2022. PMID: 36338482 Free PMC article.
-
The Temporal Topography of Central Serous Chorioretinopathy in the Chinchilla Rabbits Induced by Intravenous Injection of Adrenaline: An in vivo Study.Drug Des Devel Ther. 2022 Sep 23;16:3275-3283. doi: 10.2147/DDDT.S381957. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36177348 Free PMC article.
-
Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy.Indian J Ophthalmol. 2021 Sep;69(9):2341-2346. doi: 10.4103/ijo.IJO_3401_20. Indian J Ophthalmol. 2021. PMID: 34427217 Free PMC article. Clinical Trial.
-
Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Trans Am Ophthalmol Soc. 2015;113:T8. Trans Am Ophthalmol Soc. 2015. PMID: 26755855 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
